Founding sales lead

People judge a book by its cover. We wrote the book. You design the cover and get it on every shelf.

Two product people have been running our sales. We would like to stop. We are funded, with three customers, a working app, and a map of 7.5 million US healthcare providers. Clinical trials run late because the physicians who see the right patients never hear about the study, so we reach those physicians directly. In one trial, 89 of the 107 patients identified were interested. Now the people running those trials need to hear about us: clinical teams at sponsors, CROs and sites, plus the commercial and healthtech teams the same map serves.

You will take over the list of people we want to close, carry the number and build the system the next seller runs on. Healthcare runs on its own timetable. If you want a playbook, this is the wrong job. If you want to write one, read on.

Four in five clinical trials miss their enrollment timeline. The patients exist. The physicians who see them are twenty minutes from the site and have never heard of the study.

Spellbinder closes that gap. We mapped 7.5 million US healthcare providers, resolved from 400+ sources into one profile each: what they treat, who they share patients with, where those patients live and which trials they have enrolled into.

Two agents work the map. One reads a protocol and ranks physicians for every site, every day. The other reaches them by email and phone, then hands them to the coordinator when they say yes. You click a button and a patient shows up at the site.

It works. In one central nervous system trial, still ramping, 107 patients were identified and 89 were interested and sent to the site. That is 83%, because the ask came from their own physician and not an ad.

The same map now serves biopharma commercial teams and healthtech companies selling to providers. We are two people, and the founders have run sales so far. You would take it over.

AI is revolutionizing how drugs are discovered. The way they are tested and brought to market is still archaic, and trials still lean on marketing agencies and ads to find patients. We want people who will rethink it from first principles, with care.

We are building software that is almost invisible. We do not measure it by stickiness or time in the app. The work gets done on your behalf. We measure ourselves in the wild: are patients arriving at sites, and are physicians engaged?

Shipping the feature is only the start.

The goal is bigger than one product. We are building an entire distribution system for healthcare, with physicians fully engaged.

This is healthcare. How we treat patients sits at the center of everything we build, alongside how we treat our users.

We want someone to own sales at Spellbinder: the number, the system behind it and the story we tell. You will sell yourself first, then build the machine that lets others sell after you. You are also Spellbinder's face to our users and customers, so the job does not stop at the signature.

We have a preliminary sales motion and a list of people we want to close. What we do not have is a system that holds up without the founders in every deal. That is the job.

You will work directly with the founders, with nothing in between. You will be in the room when we decide who to sell to, what to build for them and where the company goes next. If you make the case for a channel, we will put our full effort behind it, from the website to social, ads and conferences.

It is four jobs, and they feed each other.

Close what is in front of us. Take over the list and the live conversations. Carry the deals yourself, learn why people buy and why they stall, then bring that back to the rest of the company. If a demo would close a deal, build it with AI and put it in front of the user. Work out pricing with customers directly.

Build the machine. Turn a preliminary motion into one that scales: who we target, how deals move, what we measure and how we forecast. Build it so it adapts to each new market without starting over, and so the next sellers can run it. We already find and engage customers with Clay, Apollo, La Growth Machine and Gojiberry. Push them further, find the next best thing and push us to adopt it.

Keep refining the message and the channels. Own what we say and where we say it. Test it across outbound, the marketing website, social, ads and conferences, keep what works and kill what does not. We already have some experience at conferences, and you will decide how to make them pay off.

Stay with the customer and shape the product. Keep checking in on how customers are doing after they sign. Bring their feedback back and get involved in the product: what we build, how it works and what comes next. It is a small team, and you will have a real hand in it.

One map, three buyers, each with its own language, budget and pace.

• Clinical teams. Clinical operations leaders at sponsors, CROs and site networks who need patients for their trials and better answers on where to run them.

• Commercial teams. Biopharma leaders who need to know which physicians matter for a therapy, and how to reach them.

• Healthtech companies. Startups and platforms selling to providers, who need to know which physicians to reach and what those physicians care about.

Providers sit underneath all three. Physicians are the people our agents reach, and everything we sell depends on how we treat them. If you have worked with practices, health systems or physician networks, you will know why that matters.

• Week 1: You are on real prospect calls. You have read through every deal we have open and taken ownership of the list.

• Day 30: You have talked to buyers in clinical, commercial and healthtech, and checked in with our current customers. You have told us which of our assumptions and messages are wrong.

• Day 60: Every deal lives in one system with clear stages. You own one repeatable motion from first touch to close, and you have told us which market to go after first and why.

• Day 90: You have moved deals from our list to close and built pipeline of your own. At least one channel test has real numbers behind it. You have put something you built in front of a user, and customer feedback has changed something in the product. You have a plan for conferences and for your first hire, and we are arguing about it.

• Month 6: Your sales method repeats without the founders in every deal. You have closed deals and turned them into case studies.

Picture a meeting with us. Amr comes from product design and architecture, and James from product, finance and biochemistry, so we rarely see a problem the same way. We will disagree, egos stay out of it, and we leave with a solution.

Someone will crack a joke about startups or the industry. Then we get back to work.

This is not a stuffy environment, and there is no fake startup theater. We are real people. We do not drink the Kool-Aid, or any other aid, and we are not high on our own supply.

We are relentless about the goal and open minded about the path. If the evidence says pivot, we pivot. We trust each other to put in the work, and we will trust you the same way. What you put into this company will also shape everyone who joins after you.

We love testing anything that makes us faster. When a new tool or way of working beats what we do today, we change our process and put it in place.

The care we put into our users is the level we expect from everybody here. They are used to marketing agencies and ads, and we want to be a breath of fresh air: professional and, above all, human. That goes for every email, call and booth conversation you have in our name.

• An owner. You want the number and the system behind it. When something is broken, you fix it without waiting to be asked.

• Opinionated. You will tell us when our message is wrong and show your reasoning. When the market proves you wrong, you change your mind without drama.

• A builder and a closer. You are as happy writing the first outbound sequence as you are negotiating the contract. You are not afraid to get your hands dirty, and you do not need a team to get started.

• Hardworking and fast. You run the smallest real test and kill what does not work. Every delay is a patient waiting, and we will be straight about what this job takes.

• Kind. You will be talking to busy people who owe us nothing. You listen well, you never oversell, and you make the people around you better.

• Product minded. You stay close to customers long after the close, and you have opinions on what we should build.

• Always on the best tools. You are comfortable using whatever is best in class to do the job, and you push us to do the same. That includes building and deploying your own tools and demos with AI.

• Resilient. You treat rejection as a chance to learn, and you keep going.

• 7+ years selling into life sciences or healthcare, ideally with real time at an early-stage company

• Sold to both clinical and commercial teams, and know how differently they buy

• Closed complex deals through buying committees and long cycles, and beaten your targets

• Built a sales motion from an early stage: target accounts, pipeline stages, CRM, forecasting

• Sourced your own pipeline through outbound and conferences, with nobody feeding you leads

• Worked hands on with marketing on messaging, the website and paid channels

• Built and deployed your own tools, workflows or demos with AI

• Stayed close to customers after the sale, and turned what you heard into product changes

• Adopted the best new tools on your own, and pushed your team to use them

Nice to have, not required: experience working with providers, such as practices, health systems or physician networks; selling to healthtech companies; selling data or patient recruitment services; hiring and coaching your first sellers.

We would rather you hear it now.

• It is early. There is no sales team, no sales ops, no customer success and no marketing team beyond what we build together.

• Most of the market has not heard of us yet. You will be creating awareness as well as closing.

• Three buyers is a lot for one person. You will have to choose where to go first and say no to the rest for a while.

• You will carry a number and build the system at the same time.

• Healthcare moves on its own schedule, and some deals will take longer than either of us wants.

• You will travel to customers and conferences.

• $[140K to $180K] base and $[280K to $360K] on-target earnings

• [0.75% to 1.5%] equity, on a 4-year vest with a 1-year cliff

• Health, dental and vision coverage

• A straight answer on funding and runway in our first conversation

• Our full effort behind what you want to try, from the website to social, ads and conferences

• Founders who have built at Palantir, Squarespace, Amazon, N26 and Remesh

• Full visibility into company operations, metrics and decision making

• Room to build and lead the sales team as we grow

• Conversation with Amr and James. Walk us through a sales motion you built, and tell us what you got wrong.

• Deal deep dive. One real deal from first touch to close, and the numbers behind it.

• Paid working session. Take our real message and our real list, and show us how you would run your first 30 days. Build something with AI to make your case.

• Meet a customer. Join us on a customer conversation.

• References, then an offer with the full numbers explained.

Email hello@spellbinder.ai with a sales motion you built, the numbers behind it, something you built with AI and one thing you would change about how Spellbinder sells. No cover letter needed.

Spellbinder is an equal opportunity employer. We consider all qualified applicants without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, veteran status or any other protected status.